New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 21, 2014
07:09 EDTAGN, VRXValeant, Ackman go to SEC over Allergan claims, CNBC reports
Valeant (VRX) and Bill Ackman have reached out to the SEC over what they deem as misleading and manipulative claims made by Allergan (AGN), CNBC's Andrew Ross Sorkin reports. Robert Khuzami is leading the effort for Valeant and Ackman, Sorkin adds. Valeant has also contacted regulators in Quebec, the reporter said.
News For VRX;AGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 9, 2015
11:39 EDTVRXPershing Square, Valeant, Allergan drop lawsuit over buyout
Subscribe for More Information
April 8, 2015
12:17 EDTVRXOn The Fly: Midday Wrap
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use